Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-125431
Filing Date
2024-11-12
Accepted
2024-11-12 16:15:30
Documents
81
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q orgo-20240930.htm   iXBRL 10-Q 1804491
2 EX-3.3 orgo-ex3_3.htm EX-3.3 588415
3 EX-31.1 orgo-ex31_1.htm EX-31.1 14698
4 EX-31.2 orgo-ex31_2.htm EX-31.2 15214
5 EX-32.1 orgo-ex32_1.htm EX-32.1 14451
6 GRAPHIC img226193477_0.jpg GRAPHIC 1907
  Complete submission text file 0000950170-24-125431.txt   8787396

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT orgo-20240930.xsd EX-101.SCH 1526196
84 EXTRACTED XBRL INSTANCE DOCUMENT orgo-20240930_htm.xml XML 1243375
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Filer) CIK: 0001661181 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37906 | Film No.: 241448386
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)